Advances In Sickle Cell Disease Treatment: From Drug Discovery Until The Patient Monitoring

dc.creatordos Santos J.L.
dc.creatorLanaro C.
dc.creatorChin C.M.
dc.date2011
dc.date2015-06-30T20:22:21Z
dc.date2015-11-26T14:48:38Z
dc.date2015-06-30T20:22:21Z
dc.date2015-11-26T14:48:38Z
dc.date.accessioned2018-03-28T21:59:28Z
dc.date.available2018-03-28T21:59:28Z
dc.identifier
dc.identifierCardiovascular And Hematological Agents In Medicinal Chemistry. , v. 9, n. 2, p. 113 - 127, 2011.
dc.identifier18715257
dc.identifier10.2174/187152511796196506
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-79957964590&partnerID=40&md5=5d8fa56b6beb5cf379c9d9ad5369da99
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/107706
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/107706
dc.identifier2-s2.0-79957964590
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1253669
dc.descriptionSickle Cell Disease (SCD) is one of the most prevalent hematological diseases in the world. Despite the immense progress in molecular knowledge about SCD in last years few therapeutical sources are currently available. Nowadays the treatment is performed mainly with drugs such as hydroxyurea or other fetal hemoglobin inducers and chelating agents. This review summarizes current knowledge about the treatment and the advancements in drug design in order to discover more effective and safe drugs. Patient monitoring methods in SCD are also discussed. © 2011 Bentham Science Publishers Ltd.
dc.description9
dc.description2
dc.description113
dc.description127
dc.descriptionIngram, V.M., Abnormal human haemoglobins. III. The chemical difference between normal and sickle cell haemoglobins (1959) Biochim. Biophys. Acta, 36, pp. 402-411
dc.descriptionPauling, L., Itano, H.A., Singer, S.J., Wells, I.C., Sickle cell anemia: A molecular disease (1949) Science, 110, pp. 543-548
dc.descriptionWatson, J., Stahman, A.W., Billelo, F.P., The significance of the paucity of sickle cells in neighborn negro infants (1948) Am. J. Med. Sci, 215, pp. 419-423
dc.descriptionPerutz, M.F., Rossmann, M.G., Cullis, A.F., Structure of haemo- globin: A three-dimensional Fourrier synthesis at 5-5A resolution obtained by X-ray analysis (1960) Nature, 185, pp. 416-422
dc.descriptionRicher, J., Chudley, A.E., The hemoglobinopathies and malaria (2005) Clin. Genet, 68 (4), pp. 332-336
dc.descriptionBonds, D.R., Three decades of innovation in the management of sickle cell disease: The road to understanding the sickle cell disease clinical phenotype (2005) Blood Rev, 19, pp. 99-110
dc.descriptionIlozue, C., Cipolotti, R., Melo, C.A., Gurgel, R.Q., Cuevas, L.E., Estimating the post-neonatal prevalence of sickle cell disease in a Brazilian population (2010) Trop. Med. Int. Health, 15 (10), pp. 1125-1131
dc.descriptionAdachi, K., Kim, J., Ballas, S., Surrey, S., Asakura, T., Facilitation of Hb S polymerization by the substitution of Glu for Gln at (3121 (1988) J. Biol. Chem, 263 (12), pp. 5607-5610
dc.descriptionSteinberg, M.H., Barton, F., Castro, O., Pegelow, C.H., Ballas, S.K., Kutlar, A., Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. Risk and benefits up to 9 years of treatment (2003) JAMA, 289, pp. 1645-1651
dc.descriptionZennadi, R., Chien, A., Xu, K.E., Batchvarova, M., Telen, M.J., Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium (2008) Blood, 112 (8), pp. 3474-3483
dc.descriptionTaylor, J.G., Nolan, V.G., Mendelsohn, L., Kato, G.J., Gladwin, M.T., Steinberg, M.H., Chronic hyper-hemolysis in sickle cell anemia: Association of vascular complications and mortality with less frequent vasoocclusive pain (2008) PLoS One, 3 (5), pp. 1-8
dc.descriptionKato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J., Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease (2006) Blood, 107, pp. 2279-2285
dc.descriptionEl Nemer, W., Wautier, M., Rahuel, C., Gane, P., Hermand, P., Galacteros, F., Wautier, J., Kim, C.V., Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell 41 integrin: Role in adhesion of sickle red blood cells to endothelial cells (2007) Blood, 109 (8), pp. 3544-3551
dc.descriptionWagner, M.C., Eckman, J.R., Wick, T.M., Sickle cell adhesion depends on hemodynamics and endothelial activation (2004) J. Lab. Clin. Med, 144 (5), pp. 260-267
dc.descriptionOkpala, I., Daniel, Y., Haynes, R., Odoemene, D., Goldman, J., Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells (2002) Eur. J. Haematol, 69, pp. 135-144
dc.descriptionOkpala, I., The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder (2004) Blood Rev, 18, pp. 65-73
dc.descriptionMa, Q., Wyszynski, D.F., Farrell, J.J., Kutlar, A., Farrer, L.A., Baldwin, C.T., Steinberg, M.H., Fetal haemoglobin in sickle cell anemia: Genetic determinants of response to hydroxyurea (2007) Pharma-cogenomics, 7 (6), pp. 386-394
dc.descriptionSteinberg, M.H., Pathophysiologically based drug treatment of sickle cell disease (2006) Trends Pharmacol. Scienc, 27 (4), pp. 204-210
dc.descriptionO'Connell, D., Neglected diseases (2007) Nature, 449, p. 157
dc.descriptionChung, M.C., Ferreira, E.I., Santos, J.L., Giarolla, J., Rando, D.G., Almeida, A.E., Bosquesi, P.L., Blau, L., Prodrugs for the treatment of neglected diseases (2008) Molecules, 13 (3), pp. 616-677
dc.descriptionYamey, G., Torreele, E., The world's most neglected diseases (2002) BMJ, 325 (7357), pp. 176-177
dc.descriptionPorter, J.B., Pathophysiology of transfusional iron overload: Contrasting patterns in thalassemia major and sickle cell disease (2009) Hemoglobin, 33 (S1), pp. 37-45
dc.descriptionInati, A., Khoriaty, E., Musallam, K.M., Taher, A.T., Iron chelation therapy for patients with sickle cell disease and iron overload (2010) Am. J. Hematol, 85 (10), pp. 782-786
dc.descriptionPorter, J.B., Practical management of iron overload (2001) Br. J. Haematol, 115, pp. 239-252
dc.descriptionBrittenham, G.M., Griffith, P.M., Nienhuis, A.W., McLaren, C.E., Young, N.S., Tucker, E.E., Allen, C.J., Harris, J.W., Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major (1994) N. Engl. J. Med, 331, pp. 567-573
dc.descriptionLindsey, W.T., Olin, B.R., Deferasirox for transfusion-related iron overload: A clinical review (2007) Clin. Ther, 29 (10), pp. 2154-2166
dc.descriptionWambebe, C., Khamofu, H., Momoh, J.A., Ekpeyong, M., Audu, B.S., Njoku, O.S., Bamgboye, E.A., Ogunyale, O., Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with sickle cell disorder (2001) Phytomedicine, 8 (4), pp. 252-261
dc.descriptionIyamu, E.W., Turner, E.A., Asakura, T., Niprisan (Nix-0699) improves the survival rates of transgenic sickle cell mice under acute severe hypoxic conditions (2003) Br. J. Haematol, 122 (6), pp. 1001-1008
dc.descriptionOniyangi, O., Cohal, D.H., Phytomedicines (medicines derived from plants) for sickle cell disease (2010) Cochrane Database Syst. Rev, 10, pp. CD004448
dc.descriptionEkeke, G.I., Shode, F.O., The reversion of sickle cells by Cajanus cajan (1985) Planta Med, 51 (6), pp. 504-507
dc.descriptionAkojie, F.O., Fung, L.W., Antisickling activity of hydroxybenzoic acid in Cajanus cajan (1992) Planta Med, 58 (4), pp. 317-320
dc.descriptionAkinsulie, A.O., Temiye, E.O., Akanmu, A.S., Lesi, F.E., Whyte, C.O., Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia (2005) J. Trop. Pediatr, 51 (4), pp. 200-205
dc.descriptionOuattara, B., Jansen, O., Angenot, L., Guissou, I.P., Frédérich, M., Fondu, P., Tits, M., Antisickling properties of divanilloylquinic acids isolated from Fagara zanthoxyloides Lam. (Rutaceae) (2009) Phytomedicine, 16 (2-3), pp. 125-129
dc.descriptionICAGEN: Ion Channel Advances, , http://www.icagen.com/randd/sicklecell.html, accessed November 28, 2010
dc.descriptionLew, V.L., Tiffert, T., Etzion, Z., Perdomo, D., Daw, N., Mac-Donald, L., Bookchin, R.M., Distribution of dehydration rates generated by maximal Gardos - channel activation in normal and sickle red blood cells (2005) Blood, 105 (1), pp. 361-367
dc.descriptionJoiner, C., Rettig, R.K., Jiang, M.R., Franco, P.S., Urea stimulation of KCl cotransport induces abnormal volume reduction in sickle re-ticulocytes (2007) Blood, 109, pp. 1728-1735
dc.descriptionBennekou, P., Franceschi, L., Pedersen, O., Lian, L., Asakura, T., Evans, G., Brugnara, C., Christophersen, P., Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: A possible new therapeutic approach for sickle cell disease (2001) Blood, 97 (5), pp. 1451-1457
dc.descriptionMcNaughton-Smith, G.A., Burns, J.F., Stocker, J.W., Rigdon, G.C., Creech, C., Arrington, S., Shelton, T., Franceschi, L., Novel inhibitors of the gardos channel for the treatment of sickle cell disease (2008) J. Med. Chem, 51 (4), pp. 976-982
dc.descriptionPark, S., Hayes, B.L., Marankan, F., Mulhearn, D.C., Wanna, L., Mesecar, A.D., Santarsiero, B.D., Venton, D.L., Regioselective covalent modification of hemoglobin in search of antisickling agents (2003) J. Med. Chem, 46 (6), pp. 936-953
dc.descriptionSafo, M.K., Abdulmalik, O., Danso-Danquat, R., Burnett, J.C., Nokuri, S., Joshi, G.S., Musayev, F.N., Abraham, D.J., Structural basis for the potent antisickiling effects of a novel class of five membered heterocyclic aldehydic compounds (2004) J. Med. Chem, 47, pp. 4665-4676
dc.descriptionAbdulmalik, O., Safo, M.K., Chen, Q., Yang, J., Brugnara, C., Ohene-Frempong, K., Abraham, D.J., Asakura, T., 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells (2005) Br. J. Haematol, 128, pp. 552-561
dc.descriptionKoshy, M., Dorn, L., Ressler, L., Molokie, R., Lavelle, D., Tal-Ischy, N., Hoffman, R., de Simone, J., 2-deoxy 5-azacytidine and fetal haemoglobin induction in sickle cell anemia (2000) Blood, 96 (7), pp. 2379-2384
dc.descriptionDover, G.J., Brusilow, S., Samid, D., Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate (1992) New Engl. J. Med, 327, pp. 569-570
dc.descriptionHanft, V.N., Fruchtman, S.R., Pickens, C.V., Rosse, W.F., Howard, T.A., Ware, R.E., Acquired DNA mutations associated with in vivo hydroxyurea exposure (2000) Blood, 95 (11), pp. 3589-3593
dc.descriptionCharache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., Macmahon, R.P., Bonds, D.R., The investigators of the multicenter study of hydroxyurea in sickle cell anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia (1995) N. Engl. J. Med, 332, pp. 1313-1322
dc.descriptionKing, S.B., The nitric oxide producing reactions of hydroxyurea (2003) Curr. Med. Chem, 10, pp. 437-452
dc.descriptionLou, T.F., Singh, M., Mackie, A., Li, W., Pace, B.S., Hydroxyurea generates nitric oxide in human erythroid cells: Mechanisms for gamma-globin gene activation (2009) Exp. Biol. Med, 234 (11), pp. 1374-1382
dc.descriptionConran, N., Oresco-Santos, C., Acosta, H.C., Fattori, A., Saad, S.T., Costa, F.F., Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients (2004) Br. J. Haematol, 124, pp. 547-554
dc.descriptionNahavandi, M., Perlin, E., Kassim, O.O., Wyche, M.O., Castro, O., Tavakkoli, F., Upregulation of TNF-a by hydroxyurea in patients with sickle cell anemia (2000) Blood, 96 (11), p. 14
dc.descriptionNajean, Y., Rain, J.D., Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years (1997) Blood, 90, pp. 3370-3377
dc.descriptionFruchtman, S.M., Mack, K., Kaplan, M.E., Peterson, P., Berk, P.D., Wasserman, L.R., From efficacy to safety: A Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera (1997) Semin. Hematol, 34, pp. 17-23
dc.descriptionFerm, V.H., Severe development malformations: Malformations induced by urethane and hydroxyurea in the hamster (1966) Arch. Pathol, 81, pp. 174-177
dc.descriptionDepass, L.R., Weaver, E.V., Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains (1982) J. Toxicol. Environ. Health, 10 (2), pp. 297-305
dc.descriptionSantos, J.L., Varanda, E.A., Lima, L.M., Chung, M.C., Mutagenicity of new lead compounds to treat sickle cell disease symptoms in a Salmonella/microssome assay (2010) Int. J. Mol. Sci, 11, pp. 779-788
dc.descriptionAliyu, Z.Y., Tumblin, A.R., Kato, G.J., Current therapy of sickle cell disease (2005) Haematologica, 90, pp. 7-12
dc.descriptionKonturek, S.K., Konturek, P.C., Role of nitric oxid in the digestive system (1995) Digestion, 56, pp. 1-13
dc.descriptionKaul, D.K., Zhang, X., Dasgupta, T., Fabry, M.E., Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress (2008) Am. J. Physiol. Heart Circ. Physiol, 295, pp. 39-47
dc.descriptionMorris, C.R., Kuypers, F.A., Larkin, S., Sweeters, N., Simon, J., Vichinsky, E.P., Styles, L.A., Arginine therapy: Anovel strategy to induce nitric oxide production in sickle cell disease (2000) Brit. J. Haematol, 111, pp. 498-500
dc.descriptionGladwin, M.T., Schechter, A.N., Ognibene, F.P., Coles, W.A., Reiter, C.D., Schenke, W.H., Csako, G., Cannon, R.O., Divergent nitric oxide bioavailability in men and women with sickle cell disease (2003) Circulation, 107 (2), pp. 271-278
dc.descriptionCokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T., Schechter, A.N., Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase (2003) J. Clin. Invest, 111 (2), pp. 231-239
dc.descriptionWeiner, D.L., Hibberd, P.L., Betit, P., Cooper, A.B., Botelho, C.A., Brugnara, C., Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease (2003) J. Am. Med. Assoc, 289 (9), pp. 1136-1142
dc.descriptionMack, A.K., Kato, G.J., Sickle cell disease and nitric oxide: A paradigm shift (2006) Int. J. Biochem. Cell Biol, 38, pp. 1237-1243
dc.descriptionOrringer, E.P., Casella, J.F., Ataga, K.I., Koshy, M., Adams-Graves, P., Luchtman-Jones, L., Wun, T., Grindel, J.M., Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial (2001) JAMA, 286 (17), pp. 2099-2106
dc.descriptionAdams-Graves, P., Kedar, A., Koshy, M., Steinberg, M., Veith, R., Ward, D., Crawford, R., Emanuele, M., RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: A pilot study (1997) Blood, 90 (5), pp. 2041-2046
dc.descriptionBallas, S.K., Files, B., Luchtman-Jones, L., Benjamin, L., Swerd-Low, P., Hilliard, L., Coates, T., Grindel, J.M., Safety of purified poloxamer 188 in sickle cell disease: Phase I study of a non-ionic surfactant in the management of acute chest syndrome (2004) Hemoglobin, 28 (2), pp. 85-102
dc.descriptionCheung, A.T., Chan, M.S., Ramanujam, S., Rangaswami, A., Curl, K., Franklin, P., Wun, T., Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: Computer-assisted intravital microscopy study (2004) J. Investig. Med, 52 (6), pp. 402-406
dc.descriptionGibbs, W.J., Hagemann, T.M., Purified poloxamer 188 for sickle cell vaso-occlusive crisis (2004) Ann. Pharmacother, 38 (2), pp. 320-324
dc.descriptionBrandow, A.M., Panepinto, J.A., Hydroxyurea use in sickle cell disease: The battle with low prescription rates, poor patient compliance and fears of toxicities (2010) Expert Rev. Hematol, 3 (3), pp. 255-260
dc.descriptionThornburg, C.D., Calatroni, A., Telen, M., Kemper, A.R., Adherence to hydroxyurea therapy in children with sickle cell anemia (2010) J. Pediatr, 156, pp. 415-419
dc.descriptionBarbarín, O.A., Whitten, C.F., Bond, S., Conner-Warren, R., The social and cultural context of coping with sickle cell disease: III. stress, coping tasks, family functioning and children's adjustment (1999) J. Black Psychology, 25, pp. 356-377
dc.descriptionDavies, S.C., Gilmore, A., The role of hydroxyurea in the management of sickle cell disease (2003) Blood Rev, 17, pp. 99-109
dc.descriptionRoberts, I., The role of hydroxyurea in sickle cell disease (2003) Br. J. Haematol, 120, pp. 177-186
dc.descriptionBattersby, A.J., Knox-Macaulay, H.H., Carrol, E.D., Susceptibility to invasive bacterial infections in children with sickle cell disease (2010) Pediatr. Blood Cancer, 55 (3), pp. 401-406
dc.descriptionRamakrishnan, M., Moïsi, J.C., Klugman, K.P., Iglesias, J.M., Grant, L.R., Mpoudi-Etame, M., Levine, O.S., Increased risk of invasive bacterial infections in African people with sickle-cell disease: A systematic review and meta-analysis (2010) Lancet Infect. Dis, 10 (5), pp. 329-337
dc.descriptionGaston, M.H., Verter, J.I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Falleta, J.M., Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia. A randomized trial (1986) N. Engl. J. Med, 314 (25), pp. 1593-1599
dc.descriptionWarren, M.D., Arbogast, P.G., Dudley, J.A., Kaltenbach, L., Ray, W.A., Wang, W.C., Cooper, W.O., Adherence to prophylactic antibiotic guidelines among medicaid infants with sickle cell disease (2010) Arch. Pediatr. Adolesc. Med, 164 (3), pp. 298-299
dc.descriptionTeach, S.J., Lillis, K.A., Grossi, M., Compliance with penicillin prophylaxis in patients with sickle cell disease (1998) Arch. Pediatr. Adolesc. Med, 152 (3), pp. 274-278
dc.descriptionPowell, R.W., Levine, G.L., Yang, Y., Mankad, V.N., Acute splenic sequestration crisis in sickle cell disease: Early detection and treatment (1992) J. Pediat. Surg, 27 (2), pp. 215-219
dc.descriptionEmond, A.M., Collis, R., Darvill, D., Higgs, D.R., Maude, G.H., Serjeant, G.R., Acute splenic sequestration in homozygous sickle cell disease: Natural history and management (1985) J. Pediat, 107 (2), pp. 201-206
dc.descriptionGirei, A.I., Alao, O.O., Joseph, D.E., Damulak, D.O., Orkuma, J., Banwat, E.B., Haematological profile of sickle cell anaemia in children with human parvovirus B19 infection in Jos, North Central Nigeria (2010) J. Clin. Med. Res, 2 (9), pp. 152-155
dc.descriptionCastro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillete, P., Vera, J.C., Levy, P.S., The acute chest syndrome in sickle cell disease: Incidence and risk factors: The Cooperative Study of Sickle Cell Disease (1994) Blood, 84, pp. 643-649
dc.descriptionVichinsky, E.P., Neumayr, L.D., Earles, A.N., Williamns, R., Lennette, E.T., Dean, D., Nickerson, B., Manci, E.A., Causes and outcomes of the acute chest syndrome in sickle cell disease (2000) N. Engl. J. Med, 342, pp. 1855-1865
dc.descriptionBoyd, J.H., Macklin, E.A., Strunk, R.C., Debaun, M.R., Asthma is associated with increased mortality in individuals with sickle cell anemia (2007) Haematologica, 92, pp. 1115-1121
dc.descriptionVelasquez, M.P., Mariscalco, M.M., Goldstein, S.L., Airewele, G.E., Erythrocytapheresis in children with sickle cell disease and acute chest syndrome (2009) Pedriatr. Blood Cancer, 53 (6), pp. 1060-1063
dc.descriptionLionnet, F., Arlet, J.B., Bartolucci, P., Habibi, A., Ribeil, J.A., Stankovic, K., Guidelines for management of adult sickle cell disease (2009) Rev. Med. Interne, 30 (3), pp. 162-222
dc.descriptionKumar, R., Qureshi, S., Mohanty, P., Rao, S.P., Miller, S.T., A short course of prednisone in the management of acute chest syndrome of sickle cell disease (2010) J. Pediatr. Hematol. Oncol, 32 (3), pp. 91-94
dc.descriptionSobota, A., Graham, D.A., Heeney, M.M., Neufeld, E.J., Corticos-teroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission (2010) Am. J. Hematol, 85 (1), pp. 24-28
dc.descriptionSullivan, K.J., Kisson, N., Gauger, C., Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia (2008) Pediatr. Crit. Care Med, 9 (2), pp. 159-168
dc.descriptionAtz, A.M., Wessel, D.L., Inhaled nitric oxide in sickle cell disease with acute chest syndrome (1997) Anesthesiology, 87, pp. 988-990
dc.descriptionChang, W.L., Corate, L.M., Sinclair, J.M., van der Heyde, H.C., Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement (2008) J. Investig. Med, 56, pp. 1023-1027
dc.descriptionSolomon, L.R., Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: An educational void (2008) Blood, 111 (3), pp. 997-1003
dc.descriptionRees, D.C., Olujohunghe, A.D., Parker, N.E., Stephens, A.D., Telfer, P., Wright, J., Guidelines for the management of the acute painful crisis in sickle cell disease (2003) Brit. J. Haematol, 120, pp. 744-752
dc.descriptionBooker, M.J., Blethyn, K.L., Wright, C.J., Greenfield, S.M., Pain management is sickle cell disease (2006) Chronic Illn, 2, pp. 39-50
dc.descriptionWilkie, D.J., Molokie, R., Boyd-Seal, D., Suarez, M.L., Kim, Y.O., Zong, S., Wittert, H., Wang, Z.J., Patient-reported outcomes: Descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease (2010) J. Nat. Med. Assoc, 102 (1), pp. 18-27
dc.descriptionNur, E., Kim, Y.S., Truijen, J., van Beers, E.J., Davis, S.C., Brandjes, D.P., Biemond, B.J., van Lieshout, J.J., Cerebrovascular reserve capacity is impaired in patients with sickle cell disease (2009) Blood, 114 (16), pp. 3473-3478
dc.descriptionStockman, J.A., Nigro, M.A., Mishkin, M.M., Oski, F.A., Occlusion of large cerebral vessels in sickle cell anemia (1972) N. Engl. J. Med, 287, p. 847
dc.descriptionFrench, J.A., Kenny, D., Scott, J.P., Hoffmann, R.G., Wood, J.D., Hudetz, A.G., Hillery, C.A., Mechanisms of stroke in sickle cell disease: Sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition (1997) Blood, 89 (12), pp. 4591-4599
dc.descriptionOhene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Gill, F.M., Cerebrovascular accidents in sickle cell disease: Rates and risk factors (1998) Blood, 91 (1), pp. 288-294
dc.descriptionAdams, R.J., Stroke prevention in sickle cell disease (2000) Curr. Opinion Hematol, 7 (2), p. 101
dc.descriptionAdams, R.J., Pavlakis, S., Roach, E.S., Sickle cell disease and stroke: Primary prevention and transcranial Doppler (2003) Annals Neurology, 54 (5), pp. 559-563
dc.descriptionWang, W.C., The pathophysiology, prevention, and treatment of stroke in sickle cell disease (2007) Curr. Opinion Hematol, 14 (3), pp. 191-197
dc.descriptionLefevre, N., Dufour, D., Gulbis, B., Le, P., Heijmans, C., Ferster, A., Use of hydroxyurea in prevention of stroke in children with sickle cell disease (2008) Blood, 111 (2), pp. 963-964
dc.descriptionMirre, E., Brousse, V., Berteloot, L., Lambot-Juhan, K., Verlhac, S., Boulat, C., Dumont, M., Montalembert, M., Feasi-bilty and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease (2010) Eur. J. Haematol, 84 (3), pp. 259-265
dc.descriptionSarrai, M., Duroseau, H., D'augustine, J., Moktan, S., Bellevue, R., Bone mass density in adults with sickle cell disease (2007) Brit. J. Hae-matol, 136 (4), pp. 666-672
dc.descriptionAdewoye, A.H., Chen, T.C., Ma, Q., McMahon, L., Mathieu, J., Malabanan, A., Steinberg, M.H., Holick, M.F., Sickle cell bone disease: Response to vitamin D and calcium (2008) Am. J. Hematol, 83 (4), pp. 271-274
dc.descriptionAl-Turki, H., Influence of pregnancy on bone mass in sickle cell anemia (2009) West Afric. J. Med, 28 (3), pp. 169-172
dc.descriptionDiggs, L.W., Ching, R.E., Pathology of sickle cell anemia (1934) South Med. J, 27, pp. 839-845
dc.descriptionRoupret, M., Beley, S., Traxer, O., Kirsch-Noir, F., Jouannet, P., Jardin, A., Thiounn, N., Management of priapism in patients with sickle-cell anaemia (2005) Prog. Urol, 15 (3), pp. 392-396
dc.descriptionRogers, Z.R., Priapism in sickle cell disease (2005) Hematol. Oncol. Clin. North Am, 19 (5), pp. 917-928
dc.descriptionMuneer, A., Minhas, S., Arya, M., Ralph, D.J., Stuttering priapism--a review of the therapeutic options (2008) Int. J. Clin. Pract, 62 (8), pp. 1265-1270
dc.descriptionMantadakis, E., Ewalt, D.H., Cavender, J.D., Rogers, Z.R., Buchanan, G.R., Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priap-ism (2000) Blood, 95, pp. 78-82
dc.descriptionSerjeant, G.R., Serjeant, B.E., Mohan, J.S., Clare, A., Leg ulceration in sickle cell disease: Medieval medicine in a modern world (2005) Hema-tol. Oncol. Clin. North Am, 19 (5), pp. 943-956
dc.descriptionClare, A., Fitzhenley, M., Harris, J., Hambleton, I., Serjeant, G.R., Chronic leg ulceration in homozygous sickle cell disease: The role of venous incompetence (2002) Brit. J. Haematol, 119 (2), pp. 567-571
dc.descriptionVamkavas, E.C., Relative risk of reducing the lifetime blood donation for men who have had sex with men versus currently tolerated transfusions risks (2011) Transfus. Med. Rev, 25 (1), pp. 47-60
dc.descriptionKing, A.A., Tang, S., Ferguson, K.L., de Baun, M.R., An education program to increase teacher knowledge about sickle cell disease (2005) J. School Health, 75 (1), pp. 11-14
dc.descriptionButler, D.J., Beltran, L.R., Functions of an adult sickle cell group: Education, task orientation, and support (1993) Health Soc. Work, 18 (1), pp. 49-56
dc.descriptionKladny, B., Gettig, E.A., Krishnamurti, L., Systematic follow-up and case management of the abnormal newborn screen can improve acceptance of genetic counseling for sickle cell or other hemoglo-binopathy trait (2005) Genetics Med, 7 (2), pp. 139-142
dc.descriptionJohnson, F.L., Look, A.T., Gockerman, J., Ruggiero, M.R., Dalla-Pozza, L., Billings, F.T., Bone-marrow transplantation in a patient with sickle-cell anemia (1984) N. Engl. J. Med, 311 (12), pp. 780-783
dc.descriptionGaziev, J., Lucarelli, G., Allogeneic cellular gene therapy for he-moglobinopathies (2010) Hematol. Oncol. Clin. North Am, 24 (6), pp. 1145-1163
dc.descriptionBernaudin, F., Socie, G., Kuentz, M., Chevret, S., Duval, M., Ber-Trand, Y., Vannier, J.P., Gluckman, E., SFGM-TC. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease (2007) Blood, 110 (7), pp. 2749-2756
dc.descriptionHsieh, M.M., Kang, E.M., Fitzhugh, C.D., Link, M.B., Bolan, C.D., Kurlander, R., Childs, R.W., Tisdale, J.F., Allogeneic hematopoietic stem-cell transplantation for sickle cell disease (2009) N. Engl. J. Med, 361 (24), pp. 2309-2317
dc.descriptionOlowoyeye, A., Okwundu, C.I., Gene therapy for sickle cell disease (2010) Cochrane Database Syst. Rev, 8, pp. CD007652
dc.descriptionPapanikolaou, E., Anagnou, N.P., Major challenges for gene therapy of thalassemia and sickle cell disease (2010) Curr. Gene Ther, 10 (5), pp. 404-412
dc.descriptionGräslund, T., Li, X., Magnenat, L., Popkov, M., Barbas, C.F., Exploring strategies for the design of artificial transcription factors: Targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell disease (2005) J. Biol. Chem, 280 (5), pp. 3707-3714
dc.descriptionWilber, A., Tschulena, U., Hargrove, P.W., Kim, Y.S., Persons, D.A., Barbas, C.F., Nienhuis, A.W., A zinc-finger transcrip-tional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts (2010) Blood, 115 (15), pp. 3033-3041
dc.descriptionFriedrich, M.J., Advances reshaping sickle cell therapy (2011) JAMA, 305 (3), pp. 239-240
dc.descriptionHanna, J., Wernig, M., Markoulaki, S., Sun, C.W., Meissner, A., Cassady, J.P., Beard, C., Jaenisch, R., Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin (2007) Science, 318 (5858), pp. 1920-1923
dc.languageen
dc.publisher
dc.relationCardiovascular and Hematological Agents in Medicinal Chemistry
dc.rightsfechado
dc.sourceScopus
dc.titleAdvances In Sickle Cell Disease Treatment: From Drug Discovery Until The Patient Monitoring
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución